Barclays’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,800
Closed -$3.36M 5352
2024
Q3
$3.36M Buy
35,800
+8,800
+33% +$739K ﹤0.01% 2424
2024
Q2
$2.1M Buy
+27,000
New +$2.2M ﹤0.01% 2099

Other funds holding GEHC

Barclays's GEHC Position: Q1 2026 in Review

Barclays increased its GE HealthCare (GEHC) stake by 14% in Q1 2026, buying an estimated $17.5M and bringing the position to 1,818,661 shares worth $129M. The position accounts for 0.03% of the portfolio, ranked #419.

Barclays first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $260M in Q3 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Barclays held 1,818,661 shares of GE HealthCare worth $129M as of Q1 2026.
  • Barclays bought 222,302 GE HealthCare shares in Q1 2026, an estimated $17.5M.
  • GE HealthCare made up 0.03% of Barclays's portfolio in Q1 2026, its #419 holding.
  • Barclays first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Barclays's GE HealthCare position peaked at $260M in Q3 2024.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.